Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$779,490
+$215,296 QoQ
Shares Held
11,548
-24.3% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#106
of 213 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. ANAB ranks #94 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in ANAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $779,490 | 11,548 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $564,194 | 10,173 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $500,652 | 10,327 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $365,234 | 11,928 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $221,740 | 11,928 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $162,243 | 12,254 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $410,508 | 12,254 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $307,085 | 12,254 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $248,687 | 11,043 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $236,541 | 11,043 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $198,331 | 11,043 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $224,614 | 11,043 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $240,296 | 11,043 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $342,222 | 11,043 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $281,707 | 11,043 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $224,172 | 11,043 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $273,203 | 11,043 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $244,431 | 7,034 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $190,762 | 7,034 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $292,257 | 11,271 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $242,890 | 11,271 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $242,325 | 11,271 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $166,246 | 11,271 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $251,793 | 11,271 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $159,259 | 11,271 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||